Copyright Reports & Markets. All rights reserved.

Global Preimplantation Genetics Diagnosis (PGD) Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Preimplantation Genetics Diagnosis (PGD)
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Preimplantation Genetics Diagnosis (PGD) by Type
    • 1.3.1 Overview: Global Preimplantation Genetics Diagnosis (PGD) Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Preimplantation Genetics Diagnosis (PGD) Consumption Value Market Share by Type in 2023
    • 1.3.3 Gender Selection
    • 1.3.4 Chromosomal Abnormalities
    • 1.3.5 Single Gene Disorders
    • 1.3.6 HLA Typing
    • 1.3.7 Aneuploidy
    • 1.3.8 X-Linked Diseases
    • 1.3.9 Others
  • 1.4 Global Preimplantation Genetics Diagnosis (PGD) Market by Application
    • 1.4.1 Overview: Global Preimplantation Genetics Diagnosis (PGD) Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospitals
    • 1.4.3 Clinics
    • 1.4.4 Others
  • 1.5 Global Preimplantation Genetics Diagnosis (PGD) Market Size & Forecast
  • 1.6 Global Preimplantation Genetics Diagnosis (PGD) Market Size and Forecast by Region
    • 1.6.1 Global Preimplantation Genetics Diagnosis (PGD) Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Preimplantation Genetics Diagnosis (PGD) Market Size by Region, (2019-2030)
    • 1.6.3 North America Preimplantation Genetics Diagnosis (PGD) Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Preimplantation Genetics Diagnosis (PGD) Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size and Prospect (2019-2030)
    • 1.6.6 South America Preimplantation Genetics Diagnosis (PGD) Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Preimplantation Genetics Diagnosis (PGD) Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Abbott Laboratories
    • 2.1.1 Abbott Laboratories Details
    • 2.1.2 Abbott Laboratories Major Business
    • 2.1.3 Abbott Laboratories Preimplantation Genetics Diagnosis (PGD) Product and Solutions
    • 2.1.4 Abbott Laboratories Preimplantation Genetics Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Abbott Laboratories Recent Developments and Future Plans
  • 2.2 Natera, Inc
    • 2.2.1 Natera, Inc Details
    • 2.2.2 Natera, Inc Major Business
    • 2.2.3 Natera, Inc Preimplantation Genetics Diagnosis (PGD) Product and Solutions
    • 2.2.4 Natera, Inc Preimplantation Genetics Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Natera, Inc Recent Developments and Future Plans
  • 2.3 PerkinElmer
    • 2.3.1 PerkinElmer Details
    • 2.3.2 PerkinElmer Major Business
    • 2.3.3 PerkinElmer Preimplantation Genetics Diagnosis (PGD) Product and Solutions
    • 2.3.4 PerkinElmer Preimplantation Genetics Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 PerkinElmer Recent Developments and Future Plans
  • 2.4 Illumina
    • 2.4.1 Illumina Details
    • 2.4.2 Illumina Major Business
    • 2.4.3 Illumina Preimplantation Genetics Diagnosis (PGD) Product and Solutions
    • 2.4.4 Illumina Preimplantation Genetics Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Illumina Recent Developments and Future Plans
  • 2.5 F. Hoffmann-La Roche
    • 2.5.1 F. Hoffmann-La Roche Details
    • 2.5.2 F. Hoffmann-La Roche Major Business
    • 2.5.3 F. Hoffmann-La Roche Preimplantation Genetics Diagnosis (PGD) Product and Solutions
    • 2.5.4 F. Hoffmann-La Roche Preimplantation Genetics Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 F. Hoffmann-La Roche Recent Developments and Future Plans
  • 2.6 Thermo Fisher Scientific
    • 2.6.1 Thermo Fisher Scientific Details
    • 2.6.2 Thermo Fisher Scientific Major Business
    • 2.6.3 Thermo Fisher Scientific Preimplantation Genetics Diagnosis (PGD) Product and Solutions
    • 2.6.4 Thermo Fisher Scientific Preimplantation Genetics Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.7 Laboratory Corporation of America Holdings
    • 2.7.1 Laboratory Corporation of America Holdings Details
    • 2.7.2 Laboratory Corporation of America Holdings Major Business
    • 2.7.3 Laboratory Corporation of America Holdings Preimplantation Genetics Diagnosis (PGD) Product and Solutions
    • 2.7.4 Laboratory Corporation of America Holdings Preimplantation Genetics Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Laboratory Corporation of America Holdings Recent Developments and Future Plans
  • 2.8 Agilent Technologies
    • 2.8.1 Agilent Technologies Details
    • 2.8.2 Agilent Technologies Major Business
    • 2.8.3 Agilent Technologies Preimplantation Genetics Diagnosis (PGD) Product and Solutions
    • 2.8.4 Agilent Technologies Preimplantation Genetics Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Agilent Technologies Recent Developments and Future Plans
  • 2.9 Quest Diagnostics Incorporated
    • 2.9.1 Quest Diagnostics Incorporated Details
    • 2.9.2 Quest Diagnostics Incorporated Major Business
    • 2.9.3 Quest Diagnostics Incorporated Preimplantation Genetics Diagnosis (PGD) Product and Solutions
    • 2.9.4 Quest Diagnostics Incorporated Preimplantation Genetics Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Quest Diagnostics Incorporated Recent Developments and Future Plans
  • 2.10 Cooper Surgical
    • 2.10.1 Cooper Surgical Details
    • 2.10.2 Cooper Surgical Major Business
    • 2.10.3 Cooper Surgical Preimplantation Genetics Diagnosis (PGD) Product and Solutions
    • 2.10.4 Cooper Surgical Preimplantation Genetics Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Cooper Surgical Recent Developments and Future Plans
  • 2.11 Beijing Genomics Institute (BGI)
    • 2.11.1 Beijing Genomics Institute (BGI) Details
    • 2.11.2 Beijing Genomics Institute (BGI) Major Business
    • 2.11.3 Beijing Genomics Institute (BGI) Preimplantation Genetics Diagnosis (PGD) Product and Solutions
    • 2.11.4 Beijing Genomics Institute (BGI) Preimplantation Genetics Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Beijing Genomics Institute (BGI) Recent Developments and Future Plans
  • 2.12 Genea Limited
    • 2.12.1 Genea Limited Details
    • 2.12.2 Genea Limited Major Business
    • 2.12.3 Genea Limited Preimplantation Genetics Diagnosis (PGD) Product and Solutions
    • 2.12.4 Genea Limited Preimplantation Genetics Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Genea Limited Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Preimplantation Genetics Diagnosis (PGD) Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Preimplantation Genetics Diagnosis (PGD) by Company Revenue
    • 3.2.2 Top 3 Preimplantation Genetics Diagnosis (PGD) Players Market Share in 2023
    • 3.2.3 Top 6 Preimplantation Genetics Diagnosis (PGD) Players Market Share in 2023
  • 3.3 Preimplantation Genetics Diagnosis (PGD) Market: Overall Company Footprint Analysis
    • 3.3.1 Preimplantation Genetics Diagnosis (PGD) Market: Region Footprint
    • 3.3.2 Preimplantation Genetics Diagnosis (PGD) Market: Company Product Type Footprint
    • 3.3.3 Preimplantation Genetics Diagnosis (PGD) Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Preimplantation Genetics Diagnosis (PGD) Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Preimplantation Genetics Diagnosis (PGD) Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Preimplantation Genetics Diagnosis (PGD) Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Preimplantation Genetics Diagnosis (PGD) Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Preimplantation Genetics Diagnosis (PGD) Consumption Value by Type (2019-2030)
  • 6.2 North America Preimplantation Genetics Diagnosis (PGD) Consumption Value by Application (2019-2030)
  • 6.3 North America Preimplantation Genetics Diagnosis (PGD) Market Size by Country
    • 6.3.1 North America Preimplantation Genetics Diagnosis (PGD) Consumption Value by Country (2019-2030)
    • 6.3.2 United States Preimplantation Genetics Diagnosis (PGD) Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Preimplantation Genetics Diagnosis (PGD) Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Preimplantation Genetics Diagnosis (PGD) Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Preimplantation Genetics Diagnosis (PGD) Consumption Value by Type (2019-2030)
  • 7.2 Europe Preimplantation Genetics Diagnosis (PGD) Consumption Value by Application (2019-2030)
  • 7.3 Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Country
    • 7.3.1 Europe Preimplantation Genetics Diagnosis (PGD) Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Preimplantation Genetics Diagnosis (PGD) Market Size and Forecast (2019-2030)
    • 7.3.3 France Preimplantation Genetics Diagnosis (PGD) Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Preimplantation Genetics Diagnosis (PGD) Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Preimplantation Genetics Diagnosis (PGD) Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Preimplantation Genetics Diagnosis (PGD) Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size by Region
    • 8.3.1 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Consumption Value by Region (2019-2030)
    • 8.3.2 China Preimplantation Genetics Diagnosis (PGD) Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Preimplantation Genetics Diagnosis (PGD) Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Preimplantation Genetics Diagnosis (PGD) Market Size and Forecast (2019-2030)
    • 8.3.5 India Preimplantation Genetics Diagnosis (PGD) Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Preimplantation Genetics Diagnosis (PGD) Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Preimplantation Genetics Diagnosis (PGD) Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Preimplantation Genetics Diagnosis (PGD) Consumption Value by Type (2019-2030)
  • 9.2 South America Preimplantation Genetics Diagnosis (PGD) Consumption Value by Application (2019-2030)
  • 9.3 South America Preimplantation Genetics Diagnosis (PGD) Market Size by Country
    • 9.3.1 South America Preimplantation Genetics Diagnosis (PGD) Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Preimplantation Genetics Diagnosis (PGD) Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Preimplantation Genetics Diagnosis (PGD) Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size by Country
    • 10.3.1 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Preimplantation Genetics Diagnosis (PGD) Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Preimplantation Genetics Diagnosis (PGD) Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Preimplantation Genetics Diagnosis (PGD) Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Preimplantation Genetics Diagnosis (PGD) Market Drivers
  • 11.2 Preimplantation Genetics Diagnosis (PGD) Market Restraints
  • 11.3 Preimplantation Genetics Diagnosis (PGD) Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Preimplantation Genetics Diagnosis (PGD) Industry Chain
  • 12.2 Preimplantation Genetics Diagnosis (PGD) Upstream Analysis
  • 12.3 Preimplantation Genetics Diagnosis (PGD) Midstream Analysis
  • 12.4 Preimplantation Genetics Diagnosis (PGD) Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Preimplantation Genetics Diagnosis (PGD) market size was valued at USD 99.8 million in 2023 and is forecast to a readjusted size of USD 125.7 million by 2030 with a CAGR of 3.3% during review period.
    The Global Info Research report includes an overview of the development of the Preimplantation Genetics Diagnosis (PGD) industry chain, the market status of Hospitals (Gender Selection, Chromosomal Abnormalities), Clinics (Gender Selection, Chromosomal Abnormalities), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Preimplantation Genetics Diagnosis (PGD).
    Regionally, the report analyzes the Preimplantation Genetics Diagnosis (PGD) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Preimplantation Genetics Diagnosis (PGD) market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Preimplantation Genetics Diagnosis (PGD) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Preimplantation Genetics Diagnosis (PGD) industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Gender Selection, Chromosomal Abnormalities).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Preimplantation Genetics Diagnosis (PGD) market.
    Regional Analysis: The report involves examining the Preimplantation Genetics Diagnosis (PGD) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Preimplantation Genetics Diagnosis (PGD) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Preimplantation Genetics Diagnosis (PGD):
    Company Analysis: Report covers individual Preimplantation Genetics Diagnosis (PGD) players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Preimplantation Genetics Diagnosis (PGD) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Clinics).
    Technology Analysis: Report covers specific technologies relevant to Preimplantation Genetics Diagnosis (PGD). It assesses the current state, advancements, and potential future developments in Preimplantation Genetics Diagnosis (PGD) areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Preimplantation Genetics Diagnosis (PGD) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Preimplantation Genetics Diagnosis (PGD) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
    Market segment by Type
    Gender Selection
    Chromosomal Abnormalities
    Single Gene Disorders
    HLA Typing
    Aneuploidy
    X-Linked Diseases
    Others
    Market segment by Application
    Hospitals
    Clinics
    Others
    Market segment by players, this report covers
    Abbott Laboratories
    Natera, Inc
    PerkinElmer
    Illumina
    F. Hoffmann-La Roche
    Thermo Fisher Scientific
    Laboratory Corporation of America Holdings
    Agilent Technologies
    Quest Diagnostics Incorporated
    Cooper Surgical
    Beijing Genomics Institute (BGI)
    Genea Limited
    Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Preimplantation Genetics Diagnosis (PGD) product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Preimplantation Genetics Diagnosis (PGD), with revenue, gross margin and global market share of Preimplantation Genetics Diagnosis (PGD) from 2019 to 2024.
    Chapter 3, the Preimplantation Genetics Diagnosis (PGD) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Preimplantation Genetics Diagnosis (PGD) market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Preimplantation Genetics Diagnosis (PGD).
    Chapter 13, to describe Preimplantation Genetics Diagnosis (PGD) research findings and conclusion.

    Buy now